Green tea polyphenols-induced apoptosis in human osteosarcoma SAOS-2 cells involves a caspase-dependent mechanism

Bilal Bin Hafeez1, Salahuddin Ahmed, Naizhen Wang

  • 1Division of Rheumatic Diseases, Department of Medicine, Case Western Reserve University, 2109 Adelbert Road, BRB-319, Cleveland, OH 44106-4946, USA.

Insights

Green tea polyphenols (GTP) inhibit osteosarcoma growth by blocking nuclear factor-kappaB (NF-kappaB) activation and promoting apoptosis through caspase activation. This study highlights GTP as a potential therapeutic agent for bone cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Osteosarcoma chemotherapy resistance is linked to nuclear factor-kappaB (NF-kappaB) activation.
  • Green tea polyphenols (GTP) exhibit antitumor properties against various cancer cell lines.

Purpose of the Study:

  • To investigate GTP's efficacy in inhibiting growth and inducing apoptosis in human osteosarcoma SAOS-2 cells.
  • To elucidate the molecular mechanisms underlying GTP's effects, focusing on NF-kappaB signaling and apoptosis pathways.

Main Methods:

  • SAOS-2 cells were treated with varying concentrations of GTP.
  • NF-kappaB/p65 DNA binding, protein levels, IkappaB-alpha phosphorylation, and upstream kinases (IKK-alpha/beta) were assessed.
  • Apoptosis-related proteins (Bcl-2, Bax), caspase activation (caspase-3, caspase-8), and the effects of caspase inhibitors were evaluated.

Main Results:

  • GTP treatment significantly reduced SAOS-2 cell proliferation and induced apoptosis.
  • GTP inhibited NF-kappaB activation by decreasing nuclear DNA binding and protein levels, and by reducing IkappaB-alpha phosphorylation and IKK-alpha/beta activity.
  • GTP altered Bcl-2/Bax expression, activated caspases-3 and -8, and its pro-apoptotic effects were reversed by caspase inhibitors.

Conclusions:

  • GTP demonstrates significant antiproliferative and pro-apoptotic effects on osteosarcoma cells.
  • GTP's therapeutic potential in osteosarcoma is mediated by the inhibition of NF-kappaB signaling and the activation of caspase-dependent apoptosis.
  • GTP represents a promising candidate for osteosarcoma therapy.